ARS Pharmaceuticals, Inc.

Q1 2023 13F Holders

Symbol: SPRY
CUSIP: 82835W108
Type: Equity
Class: COM
Num filings: 97
Total reported value, excl. options: $348 M

Compare 2023 Q1 to

Manager	Report Date	Value ($000)	Shares	Option Type